Transfusierisico’s en -onzekerheden

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (opent nieuw venster)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Bron‎: Surgery 2012;152(3):344-54.

Geïndexeerd‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (opent nieuw venster)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (opent nieuw venster)

Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB.

Bron‎: Arch Surg 2012;147(1):49-55.

Geïndexeerd‎: PubMed 22250113

DOI‎: 10.1001/archsurg.2011.790

https://www.ncbi.nlm.nih.gov/pubmed/22250113 (opent nieuw venster)

Adverse blood transfusion outcomes: establishing causation. (opent nieuw venster)

Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A.

Bron‎: Transfus Med Rev 2011;25(2):89-101.

Geïndexeerd‎: PubMed 21345639

DOI‎: 10.1016/j.tmrv.2010.11.001

https://www.ncbi.nlm.nih.gov/pubmed/21345639 (opent nieuw venster)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (opent nieuw venster)

Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH.

Bron‎: Crit Care Med 2006;34(6):1608-16.

Geïndexeerd‎: PubMed 16607235

DOI‎: 10.1097/01.CCM.0000217920.48559.D8

https://www.ncbi.nlm.nih.gov/pubmed/16607235 (opent nieuw venster)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (opent nieuw venster)

Marik PE, Corwin HL.

Bron‎: Crit Care Med 2008;36(9):2667-74.

Geïndexeerd‎: PubMed 18679112

DOI‎: 10.1097/CCM.0b013e3181844677

https://www.ncbi.nlm.nih.gov/pubmed/18679112 (opent nieuw venster)

Survival rate changes with transfusion of blood products during liver transplantation. (opent nieuw venster)

Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A.

Bron‎: Can J Anaesth 2005;52(2):148-55.

Geïndexeerd‎: PubMed 15684254

DOI‎: 10.1007/BF03027720

https://www.ncbi.nlm.nih.gov/pubmed/15684254 (opent nieuw venster)

Emerging infectious disease agents and their potential threat to transfusion safety. (opent nieuw venster)

Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY.

Bron‎: Transfusion 2009;49 Suppl 2:1S-29S.

Geïndexeerd‎: PubMed 19686562

DOI‎: 10.1111/j.1537-2995.2009.02279.x

https://www.ncbi.nlm.nih.gov/pubmed/19686562 (opent nieuw venster)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (opent nieuw venster)

Stramer SL.

Bron‎: ISBT Sci Ser 2014;9(1):30-6.

Geïndexeerd‎: PubMed 25210533

DOI‎: 10.1111/voxs.12070

https://www.ncbi.nlm.nih.gov/pubmed/25210533 (opent nieuw venster)

PERIOPERATIEVE ZORG

Transfusierisico’s en -onzekerheden

Nederlands

Transfusierisico’s en -onzekerheden

https://assetsnffrgf-a.akamaihd.net/assets/ct/e781f8601f/images/syn_placeholder_sqr.png

Transfusierisico’s en -onzekerheden

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (opent nieuw venster)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (opent nieuw venster)

Adverse blood transfusion outcomes: establishing causation. (opent nieuw venster)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (opent nieuw venster)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (opent nieuw venster)

Survival rate changes with transfusion of blood products during liver transplantation. (opent nieuw venster)

Emerging infectious disease agents and their potential threat to transfusion safety. (opent nieuw venster)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (opent nieuw venster)

Contact met lokale vertegenwoordiger van het ziekenhuiscontactcomité

Medische informatiepakketten

Video’s

Interview Pia Di Benedetto, MD

Transfusierisico’s en -onzekerheden

Selecteer een taal

Delen